Sr. No.	Received from	Pending at the end of last month	Received	Resolved*	Total Pending #	Pending complaints >3months	Average Resolution time^ (in days)
1	Directly from Investors	0	0	0	0	0	0
2	SEBI (SCORES)	0	0	0	0	0	0
3	Other Sources (if any)	0	0	0	0	0	0
	Grand Total	0	0	0	0	0	0

Sr. No.	Month	Carried forward from previous month	Received	Resolved*	Pending#
1	Jun, 2026	0	0	0	0
2	Jul, 2026	0	0	0	0
3	Aug, 2026	0	0	0	0
	Grand Total	0	0	0	0

Sr. No.	Fin. Year	Received	Resolved*
1	2022-23	1	1
2	2023-24	0	0
3	2024-25	0	0
4	2025-26	1	1
	Grand Total	2	2

Top Pharma Companies in India by Market Cap

BSE Sensex 74459.53 308.49 (0.42%)

Filter

Top Pharma Companies in India as on Nov-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

Expand company details	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)	More company information
61	Viyash Scientific Ltd.	Q V PT	9,653 Small Cap	218.50 (-2.82%)	56.39	3.43	20.23	2.33	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
62	Ipca Laboratories Ltd.	Q V+ PT	48,907 Mid Cap	1,927.70 (0.10%)	39.32	5.86	7.35	1.36	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
63	Concord Biotech Ltd.	Q V PT	13,028 Small Cap	1,245.30 (1.25%)	46.12	6.28	11.33	1.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
64	Syngene International Ltd.	Q V+ PT	16,252 Small Cap	402.60 (1.08%)	76.91	3.44	9.45	1.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
65	Amrutanjan Health Care Ltd.	Q V+ PT	1,436 Small Cap	496.85 (0.70%)	26.61	3.83	8.59	1.17	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
66	Metropolis Healthcare Ltd.	Q V PT	11,310 Small Cap	545.15 (-1.60%)	56.09	7.25	10.52	0.55	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
67	Gland Pharma Ltd.	Q V PT	51,112 Mid Cap	3,097.50 (0.74%)	45.28	4.81	13.18	0.09	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
68	FDC Ltd.	Q V PT	6,132 Small Cap	376.65 (-0.13%)	19.53	2.29	9.91	0.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
69	Fabtech Technologies Ltd.	Q V PT	547 Small Cap	123 (0.82%)	15.35	1.25	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
70	RPG Life Sciences Ltd.	Q V+ PT	4,255 Small Cap	2,572.40 (-14.13%)	38.89	6.19	42.67	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
71	Sanofi Consumer Healthcare India Ltd.	Q V+ PT	7,911 Small Cap	3,435.05 (-0.95%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
72	Tarsons Products Ltd.	Q V+ PT	1,552 Small Cap	291.75 (-3.98%)	139.91	2.45	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
73	Ind-Swift Laboratories Ltd.	Q V+ PT	3,246 Small Cap	367.40 (-10.14%)	38.85	2.16	-6.14	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
74	Laxmi Dental Ltd.	Q V PT	978 Small Cap	177.75 (-0.22%)	31.67	3.99	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
75	Evonile Pharma Ltd.	Q V+ PT	4,182 Small Cap	1,693.85 (-6.59%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
76	Suven Life Sciences Ltd.	Q V+ PT	7,293 Small Cap	258.10 (-2.53%)	N/A	13.1	-12.01	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
77	IOL Chemicals And Pharmaceuticals Ltd.	Q V+ PT	5,217 Small Cap	177.75 (-3.84%)	25.68	2.71	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
78	Dr. Agarwals Health Care Ltd.	Q V PT	16,117 Small Cap	508.35 (4.02%)	108.63	7.79	34.58	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
79	KMC Speciality Hospitals (India) Ltd.	Q V PT	2,422 Small Cap	148.50 (-0.67%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
80	Sanofi India Ltd.	Q V PT	7,380 Small Cap	3,204.40 (0.46%)	17.86	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
81	Dr Agarwals Eye Hospital Ltd.	Q V PT	2,552 Small Cap	5,280.15 (0.06%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
82	Wockhardt Ltd.	Q V+ PT	30,814 Small Cap	1,896.10 (-1.32%)	75.34	6.12	4.49	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
83	Orchid Pharma Ltd.	Q V PT	4,989 Small Cap	833.05 (-6.60%)	575.67	3.18	22.33	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
84	Gujarat Themis Biosyn Ltd.	Q V PT	4,718 Small Cap	362.50 (-3.29%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
85	Sai Parenterals Ltd.	Q V PT	2,302 Small Cap	521 (2.80%)	139.47	2.95	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
86	CORONA Remedies Ltd.	Q V+ PT	13,125 Small Cap	2,146.05 (-3.12%)	63.4	16.3	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
87	Anlon Healthcare Ltd.	Q V+ PT	1,378 Small Cap	25.92 (2.86%)	48.32	5.35	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
88	Park Medi World Ltd.	Q V PT	9,513 Small Cap	220.25 (-0.47%)	36.86	4.53	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
89	Jupiter Life Line Hospitals Ltd.	Q V PT	8,402 Small Cap	256.30 (-1.69%)	45.07	5.15	25.27	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
90	Medico Remedies Ltd.	Q V+ PT	155 Small Cap	18.65 (-1.84%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Anuh Pharma	87.09	8.86%
Laurus Labs	2,392	6.55%
SMS Pharmaceuticals	511.75	5.33%
Wanbury	189.75	5.10%
Zydus Lifesciences	1,244	4.89%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
RPG Life Sciences	2,572.40	-14.13%
Thyrocare Tech.	457	-11.30%
Gennex Laboratories	8.02	-10.49%
Ind-Swift Labs.	367.40	-10.14%
Cohance Lifesciences	444.45	-7.67%

News about Top Pharma Companies in India

Oct, 2026

Corona Remedies informs about newspaper publication

Corona Remedies has informed that the Board of Directors, at its meeting held on Friday, October 30, 2026 had considered and approved the Unaudited Financial Results of the Company (Standalone and Consolidated) for the second quarter and half year ended on September 30, 2026. Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, they are enclosed the newspaper advertisement of the Unaudited Financial Results, published today in Financial Express (English and Gujarati). The extract of aforesaid newspaper publication is also being made available on the website of the Company at www.coronaremedies.com

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Anlon Healthcare informs about newspaper advertisement

Anlon Healthcare has informed that it attached copy of Newspaper Advertisement dated October 31, 2026 in Financial Express (English edition) and in Financial Express (Gujarati edition) for publication of copy of extract of Financial Results for the Quarter and Half Year Ended September 30, 2026.

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Fabtech Technologies informs about investor presentation

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Fabtech Technologies has informed that it enclosed the Investor Presentation in relation to the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half-year ended September 30, 2026.

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Sanofi India - Quaterly Results

The quarter ended September 2026 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 4917.00 millions.The Profit for the quarter ended September 2026 of Rs. 1167.00 millions grew by 53.55% from Rs. 760.00 millions.Operating profit for the quarter ended September 2026 rose to 1667.00 millions as compared to 1391.00 millions of corresponding quarter ended September 2025.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202512	202412	% Var
Sales	4917.00	4754.00	3.43	14017.00	14176.00	-1.12	18374.00	20132.00	-8.73
Other Income	55.00	49.00	12.24	161.00	169.00	-4.73	197.00	165.00	19.39
PBIDT	1667.00	1391.00	19.84	4354.00	4179.00	4.19	5110.00	5073.00	0.73
Interest	2.00	4.00	-50.00	8.00	11.00	-27.27	17.00	15.00	13.33
PBDT	1665.00	1114.00	49.46	4346.00	3895.00	11.58	4820.00	4681.00	2.97
Depreciation	88.00	91.00	-3.30	267.00	278.00	-3.96	373.00	367.00	1.63
PBT	1577.00	1023.00	54.15	4079.00	3617.00	12.77	4447.00	4314.00	3.08
TAX	410.00	263.00	55.89	1051.00	967.00	8.69	1180.00	1177.00	0.25
Deferred Tax	3.00	-49.00	-106.12	4.00	-52.00	-107.69	-49.00	-81.00	-39.51
PAT	1167.00	760.00	53.55	3028.00	2650.00	14.26	3267.00	3137.00	4.14
Equity	230.00	230.00	0.00	230.00	230.00	0.00	230.00	230.00	0.00
PBIDTM(%)	33.90	29.26	15.87	31.06	29.48	5.37	27.81	25.20	10.37

Oct, 2026

Ind-Swift Labs. - Quaterly Results

A decent increase of about 50.15% in the turnover to Rs. 2348.90 millions was observed for the quarter ended September 2026. The turnover stood at Rs. 1564.33 millions during the similar quarter previous year.The Net Profit of the company reported a remarkable increase of 254.36% to Rs. 310.28 millions from Rs. 87.56 millions in previous same quarter.OP of the company witnessed a marginal growth to 499.26 millions from 200.49 millions in the same quarter last year.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	2348.90	1564.33	50.15	4209.72	3100.16	35.79	6358.88	5621.73	13.11
Other Income	75.99	118.63	-35.94	152.27	208.56	-26.99	469.55	687.48	-31.70
PBIDT	499.26	200.49	149.02	908.78	377.03	141.04	931.94	683.35	36.38
Interest	13.33	20.15	-33.85	20.38	31.66	-35.63	14.04	29.18	-51.88
PBDT	480.13	180.34	166.24	880.24	345.37	154.87	807.84	2886.21	-72.01
Depreciation	77.71	69.78	11.36	153.54	136.55	12.44	305.67	244.79	24.87
PBT	402.42	110.56	263.98	726.70	208.82	248.00	502.17	2641.42	-80.99
TAX	92.14	23.00	300.61	171.98	40.06	329.31	76.59	80.58	-4.95
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00	-54.02	-38.26	41.19
PAT	310.28	87.56	254.36	554.72	168.76	228.70	425.58	2560.84	-83.38
Equity	869.62	816.12	6.56	869.62	816.12	6.56	868.37	687.44	26.32
PBIDTM(%)	21.26	12.82	65.84	21.59	12.16	77.51	14.66	12.16	20.57

Oct, 2026

FDC - Quaterly Results

The revenue for the September 2026 quarter is pegged at Rs. 5527.90 millions, about 19.72% up against Rs. 4617.40 millions recorded during the year-ago period.Handsome Net Profit growth of 61.77% reported above the corresponding previous quarter figure of Rs. 476.90 millions to Rs. 294.80 millions.Operating profit surged to 803.10 millions from the corresponding previous quarter of 558.10 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	5527.90	4617.40	19.72	12078.90	11040.20	9.41	21263.27	20701.12	2.72
Other Income	186.20	209.10	-10.95	659.60	565.00	16.74	1110.01	1055.18	5.20
PBIDT	803.10	558.10	43.90	2704.90	2327.30	16.22	4631.81	4257.65	8.79
Interest	8.30	11.50	-27.83	16.50	23.10	-28.57	49.24	44.88	9.71
PBDT	794.80	546.60	45.41	2688.40	2304.20	16.67	4374.68	4212.77	3.84
Depreciation	159.50	151.70	5.14	310.40	300.40	3.33	591.04	536.06	10.26
PBT	635.30	394.90	60.88	2378.00	2003.80	18.67	3783.64	3676.71	2.91
TAX	158.40	100.10	58.24	580.90	487.00	19.28	924.40	940.46	-1.71
Deferred Tax	-5.00	-9.90	-49.49	20.50	27.00	-24.07	61.40	90.46	-32.12
PAT	476.90	294.80	61.77	1797.10	1516.80	18.48	2859.24	2736.25	4.49
Equity	162.80	162.80	0.00	162.80	162.80	0.00	162.81	162.81	0.00
PBIDTM(%)	14.53	12.09	20.20	22.39	21.08	6.23	21.78	20.57	5.91

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Max Healthcare Institute Ltd.	83,706 Crore
2	Artemis Medicare Services Ltd.	4,626 Crore
3	Global Health Ltd.	34,122 Crore
4	Acutaas Chemicals Ltd.	32,770 Crore
5	Kilitch Drugs (India) Ltd.	703 Crore
6	Rubicon Research Ltd.	26,650 Crore
7	Yatharth Hospital & Trauma Care Services Ltd.	8,942 Crore
8	Rainbow Childrens Medicare Ltd.	12,366 Crore
9	Sai Life Sciences Ltd.	33,139 Crore
10	Syncom Formulations (India) Ltd.	1,810 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	25,593	54,384	33.68	10.51	23.07	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,635	1,76,306	83.01	9.60	33.08	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,308	65,137	36.23	5.94	12.08	27.89
Lupin Ltd. (M)	Somewhat Good	2,009	91,870	16.62	3.86	9.20	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,512	43,891	34.76	9.03	23.33	25.35

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	2,392	1,29,243	147
Sai Life Sciences Ltd. (S)	Somewhat Good	1,560	33,139	69.37
Gland Pharma Ltd. (M)	Very Good	3,098	51,112	61.94
Aurobindo Pharma Ltd. (M)	Very Good	1,678	96,537	52.18
Ipca Laboratories Ltd. (M)	Very Good	1,928	48,907	49.58
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,560	33,139	91.61	12.98	47.25	23.61
Mankind Pharma Ltd. (M)	Very Good	2,489	1,02,797	45.84	5.85	24.28	18.10
Ajanta Pharma Ltd. (M)	Very Good	3,512	43,891	34.76	9.03	23.33	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,244	1,24,089	27.50	4.60	15.32	13.52
Gland Pharma Ltd. (M)	Very Good	3,098	51,112	45.28	4.81	23.17	13.18

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,560	33,139	91.61	12.98	47.25	39.96
Lupin Ltd. (M)	Somewhat Good	2,009	91,870	16.62	3.86	9.20	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,308	65,137	36.23	5.94	12.08	22.19
Abbott India Ltd. (M)	Very Good	25,593	54,384	33.68	10.51	23.07	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,350	1,12,699	40.25	2.90	18.79	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Current Complaints

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the month.

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the year.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Corona Remedies informs about newspaper publication

Anlon Healthcare informs about newspaper advertisement

Fabtech Technologies informs about investor presentation

Sanofi India - Quaterly Results

Ind-Swift Labs. - Quaterly Results

FDC - Quaterly Results

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?